Creatine Supplementation and Resistance Training to Preserve Muscle Mass and Attenuate Cancer Progression

Clinical Trials, Metastatic Castration Resistant Prostate Cancer (MCRPC)

— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives

NCT Number: NCT06112990
Phase: PHASE3
Trial Summary: The goal of this clinical trial is to test the use of creatine monohydrate supplementation with resistance training to preserve muscle mass and help lessen prostate cancer progression.

The main quest – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): University of Utah
Acronym: CREATINE-52

Pin It on Pinterest